News

Policy & Practice


 

DEA Accused of Electronic Stalling

The Drug Enforcement Administration, which investigates crimes involving illicit use of controlled substances, has been criticized for stalling implementation of a national electronic prescribing system for controlled substances. Sen. Sheldon Whitehouse (D-R.I.), speaking at a Senate Judiciary Committee hearing, faulted the DEA's tardiness in developing regulations for such a system and its reluctance to commit to a deadline for completing the regulations. Currently, doctors write prescriptions for controlled substances but can prescribe noncontrolled substances electronically. DEA official Joseph T. Rannazzisi told the committee that the agency is concerned an electronic system would be susceptible to abuse.

Pages

Recommended Reading

NYC Program Tries to Motivate Patients With Cash
MDedge Endocrinology
Group Investigates Genetics of Adverse Events
MDedge Endocrinology
FYI
MDedge Endocrinology
Medical Schools Boast Biggest Enrollment Ever : This was the fourth consecutive year of an increase in applicants, after a 6-year decline in applications.
MDedge Endocrinology
Employers Push Consumerism Despite Lack of Enthusiasm
MDedge Endocrinology
Health Care Safety Net Being Stretched to Breaking Point
MDedge Endocrinology
Sen. Clinton Urges Bigger Role for Nonphysicians
MDedge Endocrinology
Policy & Practice
MDedge Endocrinology
Quality Is Rising, Driven by Public Reporting, Group Says
MDedge Endocrinology
Policy & Practice
MDedge Endocrinology